| CARLSMED INC. |
| USA |
| Gesundheit |
| US14280C1053 / A41CM7 |
| I82 (Frankfurt) / CARL (NASDAQ) |
| FRA:I82, ETR:I82, I82:GR, NASDAQ:CARL |
| - |
| https://carlsmed.com/ |
|
Carlsmed, Inc. is a commercial-stage medical technology company founded in 2018 and headquartered in Carlsbad, California. It specializes in AI-enabled personalized spine surgery solutions, aiming to enhance patient outcomes and reduce healthcare cos..
>Volltext.. |
| 225.33 Mio. EUR |
| 145.21 Mio. EUR |
| 43.76 Mio. EUR |
| -26.24 Mio. EUR |
| -25.67 Mio. EUR |
| -0.99 EUR |
| 15.09 Mio. EUR |
| 74.41 Mio. EUR |
| -25.1 Mio. EUR |
| 7.7 |
| 85.94% |
| -22.17% |
| - |
| - |
| - |
| - |
| CARLSMED |
| 04.04.26 |
|
||||
|